| Name | Title | Contact Details |
|---|
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Vascular Access Teaching Aids is a Oregon City, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunesis Pharmaceuticals, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Sunesis Pharmaceuticals, Inc. is based in South San Francisco, CA. You can find more information on Sunesis Pharmaceuticals, Inc. at www.sunesis.com
Medical Practice Management Associates is a Vineland, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CareOregon Advantage is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.